rethinkTHC Search
Menu
Study breakdown

Neuropsychological testing may help tell cannabis-induced psychosis apart from schizophrenia

ReviewLow evidence
The takeaway

A review proposes that neuropsychological testing patterns could help clinicians differentiate cannabis-induced psychosis from primary psychotic disorders like schizophrenia, which often present identically on clinical exam.

Psychiatrists, neuropsychologists, early psychosis intervention teams, and mental health diagnosticians.

Cannabis-induced and primary psychosis may show distinct neuropsychological profiles

What the researchers found

Cannabis-induced psychosis and primary psychotic disorders may show different neuropsychological profiles despite similar clinical presentations. Distinct cognitive patterns could serve as diagnostic aids when clinical symptoms overlap.

Why it matters

Distinguishing cannabis-induced psychosis from schizophrenia has major treatment implications. Misdiagnosis can lead to inappropriate long-term antipsychotic treatment or, conversely, inadequate early intervention for a primary psychotic disorder.

The numbers in context

Elevated cannabis use rates in early psychosis populations make differential diagnosis clinically common. Review examines cognitive profiles across both conditions.

How the study worked

Narrative review examining neuropsychological research on cannabis-induced psychosis versus primary psychotic disorders. Proposes a cognitive testing approach to aid differential diagnosis.

What this study cannot tell us

Narrative review without systematic methodology. Neuropsychological profiles overlap between conditions. Acute intoxication effects confound cognitive testing. Proposed approach needs prospective validation.

How to read the evidence

Narrative review proposing a diagnostic approach. Needs empirical validation before clinical adoption.

When this study was published

Published 2023.

The bigger picture

As cannabis use increases, more young people present with psychotic symptoms. The ability to quickly and accurately distinguish substance-induced episodes from the onset of schizophrenia would transform clinical decision-making in early psychosis services.

Questions still open

  • Would a standardized neuropsychological battery achieve sufficient diagnostic accuracy in clinical practice? How early after psychosis onset can cognitive profiles reliably differentiate the two conditions?

Common questions

How do you tell cannabis psychosis from schizophrenia?
Currently, it is very difficult. Both present with similar symptoms (hallucinations, delusions, disorganized thinking). This review proposes that neuropsychological testing could reveal different cognitive patterns between the two, potentially aiding diagnosis, though this approach has not yet been validated in practice.
Why does the distinction matter?
Treatment differs significantly. Cannabis-induced psychosis typically resolves with cessation and short-term antipsychotic use, while schizophrenia usually requires long-term medication and psychosocial support. Misdiagnosis in either direction can lead to inappropriate treatment.

Read the original research

A neuropsychological approach to differentiating cannabis-induced and primary psychotic disorders.

Early intervention in psychiatry, 17(6), 564-572

Citation

Woolridge, Stephanie M; Wood-Ross, Chelsea; Voleti, Rohit; Harrison, Geoffrey W; Berisha, Visar; Bowie, Christopher R. (2023). A neuropsychological approach to differentiating cannabis-induced and primary psychotic disorders.. Early intervention in psychiatry, 17(6), 564-572. https://doi.org/10.1111/eip.13348

Explore the wider topic